Evidence mapPaperPMID 41502885Full record

ArticleTranslational pediatrics2025

Clinical characteristics of

Kui-Lin Lü, Ju-Hao Yang, Zi-Yun Tang, Hong Chen

Abstract read
In one paragraph

Article in Translational pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Post-pandemic resurgence and collapse ofFrontiers in public health · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kui-Lin Lü *Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Ju-Hao Yang *Department of Clinical Laboratory, The Second Affiliated Hospital of Army Medical University, Chongqing, China.
Zi-Yun Tang *Department of Information, The Second Affiliated Hospital of Army Medical University, Chongqing, China.
Hong ChenDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: In this retrospective study, we analyzed the clinical data of 541 pediatric patients with MP nucleic acid samples who were treated at a general hospital in Chongqing, China between January 2018 and December 2024. Participants were divided into an observation group [2023-2024] and a control group [2018-2022] based on their hospitalization dates. Differences in the group characteristics were compared. Results: After the relaxation of NPIs, the 2023 hospitalization rate was 5.1 times higher than that before the pandemic (11.16% Conclusions: The post-pandemic era witnessed a surge in MP infections in younger patients, with more severe cases requiring adjusted treatment strategies. This study provides critical evidence for the clinical management and public health decision-making for MP pneumonia.

Indexed as

childrencoronavirus disease 2019 (COVID-19)Mycoplasma pneumoniae (MP)pneumonia

Identifiers

PMID41502885
PMCPMC12771133

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.